Evolus Stock

Evolus EBITDA per Employee

The EBITDA per Employee of Evolus (EOLS) as of Aug 6, 2026 is -279,000.00 USD. In the previous year, EBITDA per Employee was -226,193.28 USD — a change of 23.35% (lower).

EBITDA per Employee

-279,000.00USD

YoY

23.35%

Last updated:

EBITDA per Employee of Evolus is 2026 -279,000.00 USD. EBITDA per Employee of Evolus was 2025 -226,193.28 USD. It decreases by 23.35% lower compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

EBITDA per Employee of Evolus is -279,000.00 USD in 2026.

EBITDA per Employee of Evolus changed from -226,193.28 USD to -279,000.00 USD, representing a 23.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Evolus since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Evolus historically and in real time.

Access this data via the Eulerpool API

Workforce — Evolus

All Key Metrics — Evolus